Back to
BlackRock, Inc.
LYEL5 quarters
Position history for
BlackRock, Inc.'s holdings in LYELL IMMUNOPHARMA INC
BlackRock, Inc. holds 724,342 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $10.2M as of 2026-Q2. The position was increased (+277.6% shares). LYEL represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$10.2M
Current Shares
724,342
Total Value Change
+$8.9M
Total Shares Change
+579,483
Quarter-by-Quarter History
Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC